95 related articles for article (PubMed ID: 26242267)
1. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
2. Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.
Wegiel B; Bjartell A; Tuomela J; Dizeyi N; Tinzl M; Helczynski L; Nilsson E; Otterbein LE; Härkönen P; Persson JL
J Natl Cancer Inst; 2008 Jul; 100(14):1022-36. PubMed ID: 18612129
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.
Willenbrock S; Wagner S; Reimann-Berg N; Moulay M; Hewicker-Trautwein M; Nolte I; Murua Escobar H
PLoS One; 2014; 9(6):e98788. PubMed ID: 24914948
[TBL] [Abstract][Full Text] [Related]
4. AZGP1 deficiency promotes angiogenesis in prostate cancer.
Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
[TBL] [Abstract][Full Text] [Related]
5. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
[TBL] [Abstract][Full Text] [Related]
6. Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer.
Chanda D; Lee JH; Sawant A; Hensel JA; Isayeva T; Reilly SD; Siegal GP; Smith C; Grizzle W; Singh R; Ponnazhagan S
PLoS One; 2014; 9(2):e89940. PubMed ID: 24587138
[TBL] [Abstract][Full Text] [Related]
7. CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis.
Wei Z; Zhang C; Song Y; Han D; Liu J; Song X; Chao F; Wang S; Xu G; Chen G
Cancer Lett; 2024 Apr; 588():216743. PubMed ID: 38423246
[TBL] [Abstract][Full Text] [Related]
8. Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance.
Chaiswing L; Zhong W; Liang Y; Jones DP; Oberley TD
Free Radic Biol Med; 2012 Jan; 52(2):452-61. PubMed ID: 22120495
[TBL] [Abstract][Full Text] [Related]
9. [Research on the anti-tumor effects of CRYAB in prostate cancer].
Zhang CL; Hu Y; Wang DX; Yang Q; Chang DH
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):579-286. PubMed ID: 38619403
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis.
Cheng C; Yao H; Li H; Liu J; Liu Z; Wu Y; Zhu L; Hu H; Fang Z; Wu L
Acta Pharm Sin B; 2024 Apr; 14(4):1624-1643. PubMed ID: 38572092
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
Huo C; Kao YH; Chuu CP
Cancer Lett; 2015 Dec; 369(1):103-11. PubMed ID: 26297988
[TBL] [Abstract][Full Text] [Related]
12. Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells.
Ma J; Liu J; Lu C; Cai D
Cancer Cell Int; 2015; 15():78. PubMed ID: 26244039
[TBL] [Abstract][Full Text] [Related]
13. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
14. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract][Full Text] [Related]
15. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Sweeney CJ; Chen YH; Carducci M; Liu G; Jarrard DF; Eisenberger M; Wong YN; Hahn N; Kohli M; Cooney MM; Dreicer R; Vogelzang NJ; Picus J; Shevrin D; Hussain M; Garcia JA; DiPaola RS
N Engl J Med; 2015 Aug; 373(8):737-46. PubMed ID: 26244877
[TBL] [Abstract][Full Text] [Related]
16. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.
Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M
Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
20. Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.
Cai C; Xu YF; Wu ZJ; Dong Q; Li MY; Olson JC; Rabinowitz YM; Wang LH; Sun Y
World J Urol; 2016 Apr; 34(4):561-7. PubMed ID: 26253654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
